셀트리온스킨큐어

비상장계속사업자

Celltrion Skincure Co., Ltd.

장영근

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

셀트리온스킨큐어

Business Reg. No. 1058613560 · CEO 장영근

I.Investment Overview

Target셀트리온스킨큐어 (1058613560)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명셀트리온스킨큐어
영문명Celltrion Skincure Co., Ltd.
대표자장영근
사업자등록번호1058613560
법인등록번호1101111995723
설립일2000.06.15
종업원수111명

V.Shareholders

As of 2025.12.31 · post-deal reflects dilution from the new investment (est.)

Shareholding

  • 서정진69.12%
  • 박준성3.94%
  • 유헌영2.57%
  • 기우성2.04%
  • 김형기1.80%
  • Others20.53%
ShareholderRelationSharesPrePost
서정진본인1,243,41469.12%69.12%
박준성친족70,8743.94%3.94%
기우성계열사임원36,6402.04%2.04%
김형기계열사임원32,3871.80%1.80%
유헌영계열사임원46,2422.57%2.57%
박찬홍친족5580.03%0.03%

VI.Key Executives

NameTitleCareer
장영근CEO대표 이사現 (주)셀트리온스킨큐어 대표이사
서진석기타 비상무 이사現 (주)셀트리온홀딩스 사내이사 외
김행옥기타 비상무 이사現 (주)셀트리온스킨큐어 기타비상무이사
허연회사외 이사現 (주)셀트리온스킨큐어 사외이사
황석영감사現 (주)셀트리온홀딩스, (주)셀트리온스킨큐어 감사

VII.Workforce

111

Current headcount · 2026.06 as of

VIII.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW301.42022277.82023327.420244082025
영업이익100M KRW-106.82022-63.22023-109.92024-45.82025
순이익100M KRW-8320224912023-181.92024-121.42025
Item2025202420232022
자산총계9,086.7억원8,684.1억원9,385.1억원8,433.5억원
부채총계3,483.9억원2,858.5억원3,421.9억원3,138.7억원
자본총계5,602.7억원5,825.5억원5,963.2억원5,294.7억원
매출액408억원327.4억원277.8억원301.4억원
영업이익-45.8억원-109.9억원-63.2억원-106.8억원
순이익-121.4억원-181.9억원491억원-83억원

IX.Financial Ratios

FY2025 basis

-11.23%

영업이익률

-29.76%

순이익률

51.19%

매출총이익률

-1.34%

ROA

-2.17%

ROE

62.18%

부채비율

31.65%

유동비율

61.66%

자기자본비율

24.6%

매출액증가율

-6,750원

EPS(원)

X.Audit Opinion

FY-endOpinionAuditor
2025.12.31적정의견지인회계법인
2025.12.31-
2025.12.31적정의견대현회계법인
2024.12.31적정의견지인회계법인
2024.12.31적정의견대현회계법인
2023.12.31적정대현회계법인
2022.12.31적정대현회계법인

XI.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

셀트리온스킨큐어 투심보고서 | Alpha Lenz